Ashton Thomas Private Wealth LLC Purchases 1,357 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Ashton Thomas Private Wealth LLC raised its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 153.5% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,241 shares of the medical equipment provider’s stock after purchasing an additional 1,357 shares during the period. Ashton Thomas Private Wealth LLC’s holdings in Intuitive Surgical were worth $1,170,000 as of its most recent filing with the SEC.

Several other hedge funds also recently bought and sold shares of ISRG. Massachusetts Financial Services Co. MA bought a new stake in shares of Intuitive Surgical in the 3rd quarter valued at $558,807,000. Proficio Capital Partners LLC increased its holdings in shares of Intuitive Surgical by 89,098.8% in the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock worth $495,845,000 after acquiring an additional 948,902 shares in the last quarter. FMR LLC increased its holdings in shares of Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after acquiring an additional 838,793 shares in the last quarter. Raymond James Financial Inc. bought a new position in shares of Intuitive Surgical during the 4th quarter valued at about $313,769,000. Finally, Wilmington Savings Fund Society FSB lifted its holdings in shares of Intuitive Surgical by 15,322.2% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock valued at $272,980,000 after purchasing an additional 552,058 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $518.26 on Monday. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The stock has a market cap of $184.59 billion, a price-to-earnings ratio of 80.85, a PEG ratio of 5.85 and a beta of 1.43. The firm’s 50-day moving average is $571.36 and its 200-day moving average is $531.85.

Analyst Upgrades and Downgrades

Several analysts have commented on ISRG shares. CICC Research began coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They set a “neutral” rating and a $550.00 target price on the stock. Bernstein Bank raised their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a report on Monday, January 27th. Jefferies Financial Group upped their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Finally, BTIG Research boosted their price target on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have given a buy rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 270 shares of the company’s stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,730,093.55. The trade was a 2.99 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 13,579 shares of company stock worth $7,756,844 over the last 90 days. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.